oxatomide has been researched along with Muscular Dystrophy, Duchenne in 1 studies
oxatomide: structure; an anti-allergic & an anti-asthmatic
oxatomide : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one substituted by a 3-[4-(diphenylmethyl)piperazin-1-yl]propyl group at position 1. It is an anti-allergic drug.
Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buyse, GM | 1 |
| Goemans, N | 1 |
| Henricson, E | 1 |
| Jara, A | 1 |
| van den Hauwe, M | 1 |
| Leshner, R | 1 |
| Florence, JM | 1 |
| Mayhew, JE | 1 |
| Escolar, DM | 1 |
1 trial available for oxatomide and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
CINRG pilot trial of oxatomide in steroid-naïve Duchenne muscular dystrophy.
Topics: Child; Child, Preschool; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Linear Models; | 2007 |